文献速递胸部肿瘤

丹麦首都地区I-IIIA期非小细胞肺癌患者为何被认为不可手术?基于登记的研究

Why are patients with non-small cell lung cancer in stage I-IIIA considered inoperable? A registry-based study from the capital region of Denmark.
PubMed 文献 · Eur J Cancer · 2026-01-15

该回顾性登记队列研究纳入2022年丹麦首都地区524例I-IIIA期NSCLC患者,178例(34%)未接受手术。多因素分析显示年龄≥80岁、IIIA期、ECOG较差、合并症及DLco降低或未登记与未手术独立相关。MDT记录的不手术理由主要为肺功能差或体能状态差(29.2%)、合并症(18.0%)及N2病变(11.8%),19.7%无记录理由;未发现术前运动测试记录。未调整的1年OS手术组高于非手术组(95.7% vs 82.0%)。

要点

  • 约三分之一I-IIIA期NSCLC患者未接受手术,主要因功能状态差、合并症或分期较晚。
  • 年龄≥80岁、IIIA期、ECOG差、合并症及DLco降低或未登记与未手术独立相关。
  • MDT中19.7%未手术患者无记录理由,且无术前运动测试记录,提示指南与实践存在差距。

核心结论

  • I-IIIA期NSCLC患者中约三分之一未手术,主要因功能状态受损、合并症或分期较晚。
  • 缺乏术前运动测试记录,提示指南推荐与临床实践之间存在差距。

研究设计与样本

  • 回顾性登记队列研究,纳入2022年丹麦首都地区诊断为I-IIIA期NSCLC的患者。
  • 共纳入524例患者,分为手术组和无手术组,数据来自丹麦肺癌登记和电子病历。

主要发现

  • 524例患者中178例(34%)未接受手术。
  • 未手术独立相关因素包括年龄≥80岁、IIIA期、ECOG体能状态较差、合并症、DLco降低或未登记;FEV1和DLco≥80%预计值与未手术负相关。
  • MDT记录的不手术理由为肺功能差或体能状态差(29.2%)、合并症(18.0%)、N2病变(11.8%),19.7%无记录理由。
  • 未发现术前运动测试的记录。
  • 未调整的1年OS手术组为95.7%,非手术组为82.0%。

关键数值与推荐

  • 未手术的独立相关因素:年龄≥80岁、IIIA期、ECOG体能状态较差、合并症、DLco降低或未登记。
  • FEV1和DLco≥80%预计值与未手术负相关。
  • MDT记录的不手术理由:肺功能差或体能状态差占29.2%,合并症占18.0%,N2病变占11.8%,无记录占19.7%。
  • 未调整1年OS:手术组95.7%,非手术组82.0%。

临床怎么用

  • MDT讨论时应规范记录不手术的具体理由,并考虑对功能状态存疑的患者进行客观功能评估。
  • 对于DLco降低或未登记的患者,应完善肺功能评估以辅助手术决策。
  • 指南推荐的术前运动测试在临床中可能未被充分利用,需关注其实施情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Surgical resection is first-line treatment for patients with stage I-IIIA non-small cell lung cancer (NSCLC), yet a substantial proportion are managed without surgery. The reasons for non-operative management and the role of objective functional assessment are insufficiently described. METHODS: This retrospective registry-based cohort study included patients diagnosed with stage I-IIIA NSCLC in 2022 in the Capital Region of Denmark. Data were retrieved from the Danish Lung Cancer Registry and electronic medical records. Patients were categorized into "Surgery" and "No surgery" groups. Demographic variables, lung function, ECOG performance status, comorbidities, and MDT justifications were extracted. Multivariable logistic regression identified factors associated with not receiving surgery, and one-year overall survival (OS) was estimated using Kaplan-Meier methods. RESULTS: Among 524 patients, 178 (34 %) did not undergo surgery. Non-surgical management was independently associated with age ≥ 80 years, stage IIIA disease, poorer ECOG performance status, comorbidities, and reduced or unregistered DLco, whereas FEV1 and DLco ≥ 80 % predicted were negatively associated. MDT justifications were low lung function or poor performance status (29.2 %), comorbidities (18.0 %), and N2 disease (11.8 %); in 19.7 % no justification was documented. No documentation of preoperative exercise testing was identified. One-year OS was higher after surgery than no surgery (95.7 % vs. 82.0 %), unadjusted. CONCLUSIONS: One third of patients with stage I-IIIA NSCLC were treated without surgery, mainly due to impaired functional status, comorbidity, or advanced stage. The absence of documented exercise testing highlights a gap between guideline recommendations and clinical practice.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Budolfsen T, Petersen RH, Møller LB, et al. Why are patients with non-small cell lung cancer in stage I-IIIA considered inoperable? A registry-based study from the capital region of Denmark. Eur J Cancer. 2026. PMID: 41547178. doi:10.1016/j.ejca.2026.116246

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。